Aytu BioPharma, Inc. logo

Aytu BioPharma, Inc.

NASDAQ:AYTU

Overview | Financials
Company Name Aytu BioPharma, Inc.
Symbol AYTU
Currency USD
Price 2.29
Market Cap 14,081,187
Dividend Yield 0%
52-week-range 2.11 - 3.49
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Joshua R. Disbrow
Website https://aytubio.com

An error occurred while fetching data.

About Aytu BioPharma, Inc.

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of

Related Stocks

Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc.

CLRB

2.06 USD

Sio Gene Therapies Inc. logo

Sio Gene Therapies Inc.

SIOX

0.415 USD

Landos Biopharma, Inc. logo

Landos Biopharma, Inc.

LABP

22.93 USD

Onconova Therapeutics, Inc. logo

Onconova Therapeutics, Inc.

ONTX

0.995 USD

Financials

Numbers are in millions USD

Numbers are in millions USD